Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

F002 - Lasers and Light Sources in Dermatology: How to Optimize your Results and Avoid Complications

Thursday, July 26; 9:00 AM - 11:00 AM

Learning Objectives

Following this course, the attendee should be able to:

  • Recognize appropriate clinical endpoints for assessing treatment parameters with laser, light source, and energy-based device procedures
  • Assess safe practices of laser, light source, and energy-based device procedures
  • Diagnose and effectively manage complications from laser, light source, and energy-based device procedures

Description

This session is designed for experienced laser surgeons as well as medical dermatologists seeking further education on providing safe treatments for laser, light source and energy-based device procedures. Expert faculty will emphasize how to avoid complications by reviewing topics including: laser, light source and energy-based device safety; recognizing safe and unsafe clinical endpoints; diagnosing, managing and avoiding complications.

Disclosures

  • Avram, Mathew M., MD, JD: Alastin Skincare, Inc – C(Fees); Allergan, Inc – C(Fees); Cytrellis Biosystems, Inc – C(ST); Invasix – C(Fees); Masters of Aesthetics, Inc. – F(Fees); Merz Aesthetics – C(Fees); Sciton Inc. – A(Fees); Sienna Biopharmaceuticals – A(Fees); Zalea, LLC – C(Fees); Zeltiq Aesthetics – C(Fees);
  • Ibrahim, Omer E, MD: no financial relationships exist with commercial interests.
  • Ortiz, Arisa, MD: Alastin Skincare, Inc – C(H); Allergan, Inc – A(H), SH(NC), SP(H); BTL Industries – O(EQ); Cutera, Inc. – C(H); Guthy-Renker – SP(S); InMode MD Ltd – A(H), SP(H); Merz Aesthetics – A(H); Revance Therapeutics, Inc. – I(Grants/Research Funding); Rodan and Fields – A(H); Sciton Inc. – A(H), SP(H); Sienna Biopharmaceuticals – I(Grants/Research Funding); Ulthera – Data Safety Monitoring Board(H);
  • Riyaz, Farhaad Rahman, MD: no financial relationships exist with commercial interests.
  • Saedi, Nazanin A., MD: Aerolase – I(EQ); Alastin Skincare, Inc – C(Fees); Cartessa Aesthetics – C(EQ); Cynosure, Inc – O(EQ);
  • Wulkan, Adam, MD: no financial relationships exist with commercial interests.
Schedule
Thursday, July 26
9:00 AM
Dr. Ortiz / Treatment of Vascular Disorders: Rosacea and Beyond
9:15 AM
Dr. Saedi / New Strategies to Target Pigment in All Skin Types
9:30 AM
Dr. Avram / A Combination Approach to Fractional Resurfacing
9:45 AM
Dr. Kappel / What’s New in Skin Tightening and Cellulite?
10:00 AM
Dr. Avram / The Skinny on Noninvasive Body Contouring
10:15 AM
Dr. Riyaz / Techniques for Surgical Scar Revision
10:30 AM
Dr. Ibrahim / An Effective Approach to Fractional Drug Delivery
10:45 AM
All faculty / Questions & Answers
Event Details
  • Date
    Thursday, July 26
  • Time
    9:00 AM - 11:00 AM
  • Location
    Grand Ballroom B
  • CME Credits
    2.00
  • Type
Directors/Co-Directors
  • Arisa Ortiz, MD, FAAD
Speakers
  • Adam Wulkan, MD, FAAD
  • Farhaad Rahman Riyaz, MD, FAAD
  • Mathew M. Avram, MD, JD, FAAD
  • Nazanin A. Saedi, MD, FAAD
  • Omer E Ibrahim, MD, FAAD